Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €21.03 EUR
Change Today -0.001 / 0.00%
Volume 0.0
8FM On Other Exchanges
As of 4:16 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael J. Pellini M.D., MBA

Chief Executive Officer and Director,Foundation Medicine, Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 3 different organizations across 7 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Michael J. Pellini, also known as Mike, M.D., MBA has been the Chief Executive Officer of Foundation Medicine, Inc. since May 12, 2011. Dr. Pellini has a breadth of experience in life sciences and the clinical diagnostics and laboratory industries. Dr. Pellini served as the President of Clarient, Inc. since April 28, 2008 and as its Chief Operating Officer since October 2007. While at Clarient, he worked with its leadership team to drive critical regulatory and reimbursement ...

Read Full Background

Corporate Headquarters*

150 Second Street
Cambridge, Massachusetts 02141

United States

Phone: 617-418-2200
Fax: 617-418-2201

Board Members Memberships*

Member of Executive Committee of the Board of Trustees
Director and Scientific Advisory Board Member
Chief Executive Officer and Director


Drexel University
Boston College
Thomas Jefferson University
Thomas Jefferson University School Of Medicine

Other Affiliations*

Annual Compensation*

Total Annual Compensation$415,957

Stock Options*

All Other Compensation$36,093
Exercisable Options256,147
Exercisable Options Value$5,246,317
Unexercisable Options164,759
Unexercisable Options Value$2,912,653
Total Value of Options$8,158,970
Total Number of Options420,906

Total Compensation*

Total Annual Cash Compensation$619,672
Total Short Term Compensation$415,957
Other Long Term Compensation$36,093
Total Calculated Compensation$619,672
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8FM:GR €21.03 EUR -0.001


Nachum Shamir Chief Executive Officer and President
Luminex Corporation
Gajus V. Worthington Co-Founder, Chief Executive Officer and President
Fluidigm Corporation
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
R. Bradley Gray Chief Executive Officer, President and Director
NanoString Technologies, Inc.
Bonnie H. Anderson Co-Founder, Chief Executive Officer, President, Director and Member of Non-Management Equity Award Committee
Veracyte, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FOUNDATION MEDICINE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at